These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Discriminating neoantigenic differences between fibrinogen and fibrin derivatives. Plow EF; Edgington TS Proc Natl Acad Sci U S A; 1973 Apr; 70(4):1169-73. PubMed ID: 4123931 [TBL] [Abstract][Full Text] [Related]
7. Fibrin lysis by thrombin elevating levels of fibrinogen and fibrin-related antigen (FR-antigen) in human serum as shown by Auto Analyzer assay. Merskey C; Johnson AJ; Lalezari P J Clin Pathol; 1972 Jul; 25(7):623. PubMed ID: 5070262 [No Abstract] [Full Text] [Related]
8. The quantitation of fibrinogen or fibrin split products. Some critical remarks. Merskey C Thromb Diath Haemorrh Suppl; 1969; 36():195. PubMed ID: 4246463 [No Abstract] [Full Text] [Related]
9. The identification of fibrinogen derivatives in plasma and serum by agarose gel filtration. Vermylen J; Donati MB; Verstraete M Scand J Haematol Suppl; 1971; 13():219-23. PubMed ID: 4258201 [No Abstract] [Full Text] [Related]
10. Isolation of fibrinogen-fibrin related antigen from human plasma by immuno-affinity chromatography: its characterization in normal subjects and in defibrinating patients with abruptio placentae and disseminated cancer. Merskey C; Johnson AJ; Harris JU; Wang MT; Swain S Br J Haematol; 1980 Apr; 44(4):655-70. PubMed ID: 7378321 [TBL] [Abstract][Full Text] [Related]
11. Immunoephelometric determination of fibrinogen and its derivatives in plasma. Farrell GW; Wolf P J Immunol Methods; 1972 May; 1(3):217-29. PubMed ID: 4116307 [No Abstract] [Full Text] [Related]
12. Fibrin degradation products in normal and abnormal pregnancy and parturition. Bonnar J; Davidson JF; Pidgeon CF; McNicol GP; Douglas AS Br Med J; 1969 Jul; 3(5663):137-40. PubMed ID: 5306093 [TBL] [Abstract][Full Text] [Related]
13. [Products of fibrinolytic cleavage and their clinical significance]. Astedt B; Nilsson IM Folia Haematol Int Mag Klin Morphol Blutforsch; 1972; 97(1):84-94. PubMed ID: 4114588 [No Abstract] [Full Text] [Related]
14. Increase in fibrinogen and fibrin-related antigen in human serum due to in vitro lysis of fibrin by thrombin. Merskey C; Johnson AJ; Lalezari P J Clin Invest; 1972 Apr; 51(4):903-11. PubMed ID: 5014617 [TBL] [Abstract][Full Text] [Related]
16. Quantitative determination of fibrin and fibrinogen in biological material. Haeberli A; Straub PW J Lab Clin Med; 1980 Aug; 96(2):258-66. PubMed ID: 6447180 [TBL] [Abstract][Full Text] [Related]
17. A SIMPLE RAPID METHOD FOR ESTIMATING SERUM PLASMIN ACTIVITY WITH FIBRIN-COATED LATEX PARTICLES. FERREIRA HC Blood; 1965 Feb; 25():258-60. PubMed ID: 14267701 [No Abstract] [Full Text] [Related]
18. [THE PHYSIOPATHOLOGY OF FIBRINOLYSIS AND ITS CLINICAL AND THERAPEUTIC APPLICATIONS]. SAMAMA M Transfusion (Paris); 1964; 7():99-125. PubMed ID: 14168287 [No Abstract] [Full Text] [Related]
19. Detection of fibrinogen-fibrin degradation products by counterelectrophoresis. Brody JI J Clin Pathol; 1972 Sep; 25(9):754-6. PubMed ID: 5086217 [TBL] [Abstract][Full Text] [Related]
20. [Diagnostic significance of proteolytic breakdown products of fibrinogen and fibrin]. Heene DL; Genth K Internist (Berl); 1984 Feb; 25(2):93-101. PubMed ID: 6231262 [No Abstract] [Full Text] [Related] [Next] [New Search]